PDMR dealing
EKF Diagnostics Holdings plc (AIM: EKF) announces that on 21 March 2017, the Company was notified that Harwood Capital LLP ("Harwood") acquired 8,000,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT"). Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood and a director and shareholder in NAIT.
Following the above transaction, which was completed on 20 March 2017 at a price of 19.5p pence per share, NAIT's interest is now in 98,000,000 Ordinary Shares, representing 21.12% of the Company's issued share capital. The interests of Oryx International Growth Fund Limited ("Oryx", whose investment adviser is Harwood) remains as previously disclosed in 40,000,000 Ordinary Shares, representing 8.62% of the Company's issued share capital. Mr Mills is also a director and shareholder in Oryx.
The total indirect beneficial interest of Mr Mills is, following the above transaction, therefore now in 138,000,000 Ordinary Shares, representing 29.73% of the Company's issued share capital.
| EKF Diagnostics Holdings plc Julian Baines, CEO Richard Evans, Finance Director and COO |
00 44 29 2071 0570 |
| N+1 Singer Alex Price / Alex Laughton-Scott |
00 44 20 7496 3000 |
|
Walbrook PR Limited |
00 44 20 7933 8780 or ekf@walbrookpr.com 00 44 7980 541 893 00 44 7584 391 303 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Harwood Capital LLP, as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT") |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood Capital LLP and a director and shareholder in NAIT |
||||
|
b) |
Initial notification /Amendment |
Initial Notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
EKF Diagnostics Holdings plc |
||||
|
b) |
LEI |
213800DXTF3EAUK1AR05 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrumentIdentification code |
Ordinary shares of 1p each (“Ordinary Shares”) ISIN Code: GB0031509804 |
||||
|
b) |
Nature of the transaction |
Acquisition of shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information |
n/a |
||||
|
e) |
Date of the transaction |
20 March 2017 |
||||
|
f) |
Place of the transaction |
London Stock Exchange |
||||
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.